financetom
Business
financetom
/
Business
/
This retail stock is a good long term compounding story. Should you buy it?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This retail stock is a good long term compounding story. Should you buy it?
Jul 17, 2023 4:32 AM

Grocery chain, DMart reported a muted show in the first quarter of FY24 with earnings before interest, tax, depreciation and amortisation (EBITDA) being 10 percent below consensus estimates. This was driven by 120 bps decline in gross margins of 14.6 percent, attributed to a lower mix of general merchandise and apparel.

Share Market Live

NSE

Revenue/sq.ft grew 4 percent year on year to Rs 34,400, but is still below the pre-pandemic levels. The store openings have also slowed down to 3 in the June ended quarter.

DMart is down 5 percent in the past one year and 8 percent since start of this year.

Should investors look at buying the stock?

During FY12 to FY20, DMart sustained consistent same store sales growth above 15 percent. However, that has come off with older stores maturing. The company now faces increased competition from other E-Commerce players.

Abneesh Roy, Analyst at Nuvama institutional Equities says "from a two years perspective, this is a good compounding story." DMart is seen as a good proxy to the overall consumption compounding story. Roy adds "there is a huge runway to add stores in states, other than Gujarat and Maharashtra."

Roy says "DMart is a good long term story, but will face near term pressure." The stock currently trades at Rs 3,740 on NSE and Nuvama has 'hold' rating with a target price of Rs 4,015.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LGI Homes Foreclosure Rates 4x Higher Than FHA Average, Hunterbrook Report Alleges
LGI Homes Foreclosure Rates 4x Higher Than FHA Average, Hunterbrook Report Alleges
Sep 29, 2025
Shares of homebuilder LGI Homes Inc ( LGIH ) are trading lower Monday morning after a report by Hunterbrook Media accused the company of luring renters into buying homes they cannot afford through deceptive marketing and aggressive sales tactics. What To Know: The report, titled “Buyer’s Remorse,” alleges LGI Homes ( LGIH ) targets low-income individuals with ads for unrealistically...
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says
Sep 29, 2025
11:38 AM EDT, 09/29/2025 (MT Newswires) -- Genmab's ( GMAB ) $8 billion offer for Merus (MRUS) represents a good deal that largely reflects the value of Merus' petosemtamab as a treatment for head and neck cancer, Truist Securities said in a Monday note. The all-cash transaction was announced earlier today, under which a Genmab ( GMAB ) unit will...
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
Sep 29, 2025
11:31 AM EDT, 09/29/2025 (MT Newswires) -- MoonLake Immunotherapeutics' ( MLTX ) SLK showed limited effectiveness in treating hidradenitis suppurativa which is likely to impact its sales and potential in other competitive markets like psoriatic arthritis, RBC Capital Markets said in a note Monday. SLK's phase 3 trial in hidradenitis suppurativa produced mixed results, with one study reaching statistical significance...
-- Highlander Silver Brief: National Bank Notes Expects
-- Highlander Silver Brief: National Bank Notes Expects "Surfacing Value Through 'Fast Tracking' Ayelen to Production Will Gain More Attention"
Sep 29, 2025
11:26 AM EDT, 09/29/2025 (MT Newswires) -- Price: 4.03, Change: +0.23, Percent Change: +6.05 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved